Related Experiment Videos
Persistent thrombocytopenia during remission in acute leukemia does not preclude long-term disease-free survival
American Journal of Hematology
|November 1, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Correction: Veeramani et al. Quantifying PD1 Saturation by PDL1 in Tumor Tissue Using a Novel RNA Aptamer-Based Assay. Int. J. Mol. Sci. 2026, 27, 5469.
International journal of molecular sciences·2026
Quantifying PD1 Saturation by PDL1 in Tumor Tissue Using a Novel RNA Aptamer-Based Assay.
International journal of molecular sciences·2026
Quantifying PD1 saturation by PDL1 in tumor tissue using a novel RNA aptamer-based assay.
bioRxiv : the preprint server for biology·2026
Intratumoral Virus-Like Particles Containing a TLR9 Agonist Combined with Systemic αPD-1 Activate Tumor-Specific CD8+ T Cells.
Cancer research communications·2026
Primary Plasma Cell Leukemia.
American journal of hematology·2026
Real-World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: The PETHRATIFY Study.
American journal of hematology·2026
HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities.
American journal of hematology·2026
Targeting B-Cell-Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia.
American journal of hematology·2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
American journal of hematology·2026